KR20140062230A - Fermented bellflower pills and preparation thereof - Google Patents
Fermented bellflower pills and preparation thereof Download PDFInfo
- Publication number
- KR20140062230A KR20140062230A KR1020120128608A KR20120128608A KR20140062230A KR 20140062230 A KR20140062230 A KR 20140062230A KR 1020120128608 A KR1020120128608 A KR 1020120128608A KR 20120128608 A KR20120128608 A KR 20120128608A KR 20140062230 A KR20140062230 A KR 20140062230A
- Authority
- KR
- South Korea
- Prior art keywords
- fermented
- weight
- hot water
- mixing
- mixture
- Prior art date
Links
- 241000332371 Abutilon x hybridum Species 0.000 title claims description 22
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 239000006187 pill Substances 0.000 title abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 18
- 239000012141 concentrate Substances 0.000 claims abstract description 14
- 238000003809 water extraction Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 11
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 11
- 229940041616 menthol Drugs 0.000 claims description 11
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 10
- 235000008397 ginger Nutrition 0.000 claims description 10
- 239000008188 pellet Substances 0.000 claims description 10
- 235000012907 honey Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 5
- 239000008101 lactose Substances 0.000 claims description 5
- 235000014443 Pyrus communis Nutrition 0.000 claims description 4
- 240000008042 Zea mays Species 0.000 claims description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 241000226211 Salminus brasiliensis Species 0.000 claims description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims 2
- 235000005822 corn Nutrition 0.000 claims 2
- 244000208874 Althaea officinalis Species 0.000 claims 1
- 235000006576 Althaea officinalis Nutrition 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 240000006394 Sorghum bicolor Species 0.000 claims 1
- 210000001015 abdomen Anatomy 0.000 claims 1
- 235000001035 marshmallow Nutrition 0.000 claims 1
- 235000015277 pork Nutrition 0.000 claims 1
- 235000008216 herbs Nutrition 0.000 abstract description 16
- 239000000284 extract Substances 0.000 abstract description 10
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract description 8
- 230000006872 improvement Effects 0.000 abstract description 7
- 230000007177 brain activity Effects 0.000 abstract description 5
- 230000007721 medicinal effect Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 240000003582 Platycodon grandiflorus Species 0.000 abstract 6
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 208000026435 phlegm Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 230000000144 pharmacologic effect Effects 0.000 description 10
- 241000411851 herbal medicine Species 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 241000234314 Zingiber Species 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 7
- 230000004151 fermentation Effects 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 238000010298 pulverizing process Methods 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 241000220324 Pyrus Species 0.000 description 4
- 244000062793 Sorghum vulgare Species 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- -1 glucose and fructose Chemical class 0.000 description 4
- GYHFUZHODSMOHU-UHFFFAOYSA-N nonanal Chemical compound CCCCCCCCC=O GYHFUZHODSMOHU-UHFFFAOYSA-N 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 244000082204 Phyllostachys viridis Species 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 239000011425 bamboo Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 150000002989 phenols Chemical class 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- DTGKSKDOIYIVQL-NQMVMOMDSA-N (+)-Borneol Natural products C1C[C@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-NQMVMOMDSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000006587 Glutathione peroxidase Human genes 0.000 description 2
- 108700016172 Glutathione peroxidases Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 244000274050 Platycodon grandiflorum Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003793 antidiarrheal agent Substances 0.000 description 2
- 229940125714 antidiarrheal agent Drugs 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000002956 ash Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 229910000078 germane Inorganic materials 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000002363 herbicidal effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 230000006993 memory improvement Effects 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 239000001841 zingiber officinale Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- IFPMZBBHBZQTOV-UHFFFAOYSA-N 1,3,5-trinitro-2-(2,4,6-trinitrophenyl)-4-[2,4,6-trinitro-3-(2,4,6-trinitrophenyl)phenyl]benzene Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C=2C(=C(C=3C(=CC(=CC=3[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)C(=CC=2[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)=C1[N+]([O-])=O IFPMZBBHBZQTOV-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 241001532026 Liriope muscari Species 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000233614 Phytophthora Species 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000007230 Sorghum bicolor Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000006851 antioxidant defense Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000021463 dry cake Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940102465 ginger root Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- JPTOCTSNXXKSSN-UHFFFAOYSA-N methylheptenone Chemical compound CCCC=CC(=O)CC JPTOCTSNXXKSSN-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical group 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/46—Spray-drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Abstract
Description
본 발명은 발효도라지환 및 이의 제조방법에 관한 것이다. 보다 구체적으로, 발효된 도라지 추출물에 한방약초를 혼합 농축시킨 발효도라지환 및 이의 제조방법에 관한 것이다.
FIELD OF THE INVENTION The present invention relates to a fermented Doroji ring and a method for producing the same. More particularly, the present invention relates to a fermented Dorayhoe ring mixed with oriental herbal medicine and fermented Doraji extract and a process for producing the same.
약초는 한의약 및 민간요법으로 사용된 의약품이자 농가의 소득원으로서 실생활과 밀접한 관계에 있다. 근래에는 약초를 소재로 하는 산업들이 발전함에 따라 식료품, 천연 의약품, 신약 화합물 또는 건강 생활용품 등 다양한 분야에서 도라지를 포함한 다양한 약초가 활용되고 있다.Herbs are medicines used as herbal medicines and folk remedies, and as income sources for farm households, they are closely related to the real life. In recent years, as herb-based industries have developed, various herbs including bellflower have been used in a variety of fields such as foodstuffs, natural medicines, new drug compounds or health care products.
또한, 도라지와 같이 식품으로 개발이 가능한 약초 산업의 효과적인 성장을 위해 국가적 차원의 지원과 산업적 투자로 약초 자원에 대한 규격화가 추진되고 있다. 이러한 약초의 규격화 및 대중화를 이룬 대표적인 것이 용각산이다. 용각산은 도라지, 원지 및 세네가 등으로 이루어진 건조약재의 분말이 혼합된 초미세 분말이다. 이들 약재의 거담작용으로 인해 가래를 제거하여 인후염을 완화시키는 건강보조식품이다. 그러나, 용각산은 좋은 효능과 휴대성에도 불구하고 특유의 강한 향과 노인층의 전유물이라는 잘못된 인식으로 소비층이 한정되어 있다. 따라서, 도라지와 한방약초를 이용한 차별화된 향과 기능으로 소비자의 선입견을 회피하고, 폭 넓은 소비층을 형성할 수 있는 대체품의 개발이 필요한 실정이다.In addition, for the effective growth of the herbal medicine industry, which can be developed as food, such as bellflower, standardization of herbal resources is being promoted through national support and industrial investment. A representative example of the herbicide standardization and popularization is Yonggak San. Yonghak San is an ultrafine powder mixed with dry powders of pharmacopoeia composed of bellflower, raw paper and Senega. It is a dietary supplement that alleviates sore throat by eliminating sputum due to the hyperactivity of these medicines. However, in spite of its good efficacy and portability, Yonghak - san has a limited number of consumers because of its unique strong incense and misperception that it is the only product of the elderly. Therefore, it is necessary to develop substitute products that can avoid consumers' prejudice and form a wide range of consumers with differentiated flavor and function using bellflower and herbal medicine.
종래 기술로서, 한국등록특허공보 제10-1043509호에는 건강기능식품의 제조 방법이 기재되어 있다.
As a conventional technique, Korean Patent Registration No. 10-1043509 describes a method for producing a health functional food.
이와 같은 기술적 배경 하에서, 본 발명자들은 예의 노력한 결과, 발효도라지환 및 이의 제조방을 개발하기에 이르렀다.Under these technical backgrounds, the present inventors have made intensive efforts to develop a fermentation broth and a preparation room therefor.
결국 본 발명의 목적은 발효된 도라지 추출물에 한방약초를 혼합 농축시켜 거담 기능개선 및 두뇌활동 촉진에 관한 약리작용이 있는 발효도라지환 및 이의 제조방법에 관한 것이다.
Accordingly, an object of the present invention is to provide a fermented Dorafill ring having a pharmacological action for enhancing the genomic function and enhancing brain activity by mixing and concentrating herb medicine with fermented Platycodon grandiflorum extract and a method for producing the same.
상기와 같은 기술적 과제를 해결하기 위해,In order to solve the above technical problem,
본 발명의 일 측면에 따르면, 도라지, 더덕, 배, 수수, 맥문동 및 생강을 혼합하여 열수 추출재료를 얻는 단계; 상기 얻어진 열수 추출재료를 열수 추출하여 농축액을 얻는 단계; 상기 얻어진 농축액에 발효균을 접종하여 발효시키는 단계; 상기 발효된 농축액을 가열 멸균 후 분무 건조하여 건고물을 얻는 단계; 상기 건조된 건고물에 배초향 분말을 혼합하여 혼합물을 얻는 단계; 상기 얻어진 혼합물에 꿀 및 멘톨을 혼합 교반하여 환제로 제조하는 단계; 및 상기 제조된 환제를 121 ± 10℃의 온도 조건에서, 수분 함량이 20% 미만이 되도록 건조하는 단계;를 포함하는 발효도라지환의 제조방법이 제공될 수 있다.According to an aspect of the present invention, there is provided a method for producing a hot-water extracting material, comprising the steps of: Extracting the obtained hot water extraction material with hot water to obtain a concentrated liquid; Fermenting the obtained concentrated liquid by inoculating the fermenting bacteria; Heating and sterilizing the fermented concentrate followed by spray drying to obtain a dried product; Mixing a dried powder with the dried powder to obtain a mixture; Mixing the obtained mixture with honey and menthol to prepare a pellet; And drying the prepared pellets to a moisture content of less than 20% at a temperature of 121 ± 10 ° C.
본 발명의 다른 측면에 따르면, 상기 방법으로 제조된 발효도라지환이 제공될 수 있다.According to another aspect of the present invention, there can be provided a fermented dalyeoseol produced by the above method.
본 발명에 따르면, 발효된 도라지 추출물에 한방약초를 혼합 농축시켜 거담 기능개선 및 두뇌활동 촉진에 관한 약리 효과가 있는 발효도라지환 및 이의 제조방법이 제공되며, 이에 따라 약리 효과가 있는 발효된 도라지 추출물 및 다양한 한방약초를 휴대가 용이하며, 산제와는 달리 복용량이 일정한 장점이 있는 환제로 조제할 수 있다.
According to the present invention, there is provided a fermented Dorojiru ring having pharmacological effect on improvement of the genomic function and brain activity promotion by mixing and concentrating herbal medicine with fermented bellflower extract, and a process for producing the same, and thus, a fermented bellflower extract And various oriental medicinal herbs are easy to carry, and unlike powders, they can be prepared as pills with a certain dose.
도 1은 본 발명의 일 실시예에 따른 발효도라지환의 제조방법을 나타낸 흐름도이다.
도 2는 본 발명의 일 실시예에 따른 발효도라지환의 제조방법 중 열수 추출 건고물을 준비하는 과정을 나타낸 흐름도이다. 1 is a flowchart illustrating a method of manufacturing a fermented Dorraji ring according to an embodiment of the present invention.
FIG. 2 is a flowchart illustrating a process of preparing a hot water extracting trough in a method of manufacturing a fermented Dorraji ring according to an embodiment of the present invention.
이하, 본 발명을 보다 상세하게 설명한다.
Hereinafter, the present invention will be described in more detail.
본 발명에 따른, '도라지'는 초롱꽃과에 속하는 여러해살이풀 또는 그 뿌리로서, 수분 85%, 단백질 1.8%, 지질 0.2%, 다질 10.4%, 섬유 2.4% 및 회분 0.5%를 함유하고 있다. 도라지는 당분과 섬유질이 많고 철분과 칼슘이 많은 우수한 알칼리성 식품이다. 도라지 뿌리에는 단백질, 당분, 칼슘, 철분, 회분 및 인과 같은 무기질을 포함하고 있으며, 비타민 B1 및 B2를 포함한 다양한 비타민을 포함하고 있는 알칼리성 식품이다. According to the present invention, 'bellflower' is a perennial plant belonging to the genus Chrysanthemum or its root and contains 85% moisture, 1.8% protein, 0.2% lipid, 10.4% polychalia, 2.4% fiber and 0.5% ash. Bellflower is an excellent alkaline food rich in sugar and fiber, rich in iron and calcium. The bellflower root contains minerals such as protein, sugar, calcium, iron, ash and phosphorus. It is an alkaline food containing various vitamins including vitamin B1 and B2.
도라지는 항산화, 기억력개선, 콜레스테롤 저하, 혈압상승 억제, 혈당상승 억제, 혈소판응집 억제, 항균작용, 항알레르기작용, 모세혈관 저항성 증가, 중추신경 흥분작용, 항천식, 거담작용, 감기예방 및 항암 등에 있어서 약리 효과를 보인다. 도라지의 주요 약리성분은 트리테르페노이드(triterpenoid)계 사포닌으로 밝혀졌으며 기관지분비를 항진시켜 가래를 삭히는 효능이 있다. 도라지에서만 특별히 관찰되는 사포닌 성분은 진정, 해열, 진통, 진해, 거담, 혈당 강하, 콜레스테롤 대사개선, 항콜린, 항암작용 및 위산분배 억제효과 등 여러 약리 효과가 있는 것으로도 밝혀져 있다. 또한, 도라지에 함유된 이눌린(inulin) 성분은 생쥐를 이용한 항암 실험에서 강력한 항암 활성을 보였다.The bellflower contains antioxidants, antioxidants, antioxidants, antioxidants, antidiarrheal agents, antidiarrheal agents, anti-cold agents, anticancer agents, antioxidants, antioxidants, Thus showing pharmacological effects. The main pharmacological component of the bellflower is triterpenoid saponin, and it has the effect of clearing the sputum by increasing bronchial secretion. The saponin component, which is observed only in the bellflower, has been shown to have various pharmacological effects such as caloric, antipyretic, analgesic, shinhae, germane, hypoglycemic effect, cholesterol metabolism improvement, anticholinergic, anticancer effect and gastric acid distribution inhibition effect. Also, the inulin component contained in the bellflower showed a strong anticancer activity in the anticancer test using mice.
본 발명에 따른, '더덕(沙蔘, Codonopsis lanceolata Bench. et Hook.)'은 한국, 중국 및 일본의 산간지방에서 야생하는 다년생 초본으로 도라지와 함께 일반식용으로 널리 이용되고 있는 산채식품이다. 더덕은 기호품으로도 상당한 호평을 받는 식품일 뿐 아니라 진해 및 거담 등의 약효가 있다고 알려져 있으며, 혈적, 경기, 두통 및 소염제 또는 인삼의 대용약으로 쓰이고 있다. 더덕의 주성분은 사포닌, 이눌린 및 플라보노이드 등으로 알려져 있고, 혈청 지질의 감소효과, 면역력 증가 및 더덕 에탄올 추출물투여 동물실험결과 생체내 항산화 방어시스템인 글루타싸이온 퍼옥시다아제(GPX) 및 글루타싸이온 리덕타아제(GR)의 활성이 증가되었고, 항산화 효과에 의한 지질 수준 저하로 유도됨이 밝혀졌다.According to the present invention, 'Codonopsis lanceolata Bench. Et Hook.' Is a perennial herb that is wild in mountainous regions of Korea, China and Japan, and is a wild food widely used for general food with bellflower. Doduck is not only a food that is well received as a praise product but also has a medicinal effect such as Jinhae and Gadam, and is used as a substitute for blood, sports, headache, anti-inflammatory agent or ginseng. The main components of dodeca are known as saponin, inulin and flavonoids, and the effects of reducing serum lipids, increasing immunity and administration of ethoxylated ethanol extracts showed that the in vivo antioxidant defense systems glutathione peroxidase (GPX) and glutathione It was found that the activity of reductase (GR) was increased and induced by the antioxidant effect.
본 발명에 따른, '배(pear, Pyrus pylifolia Nakai)'는 포도당, 과당 등의 당질과 비타민 B와 C, 식이섬유가 풍부한 알칼리성 식품으로 사과, 감귤, 포도와 더불어 우리나라 4대 과실중하나이지만 전통 한방에서 변비, 이뇨, 기침 등의 치료 목적으로 사용되어 왔다. 최근에는 배의 주요성분중 하나인 펙틴(pectin)이 항당뇨, 혈중 콜레스테롤 저하, 소화장애 개선 및 심혈관계 장애 개선에 효과를 갖는다는 것이 밝혀졌다. 또한, 배에는 펙틴 등 고분자 다당류 이외에도 카테킨(catechin), 알부틴(albutin), 클로로겐산(chlorogenic acid), 카페산(caffeic acid), 에피카테킨(epicatechin) 및 루틴(rutin) 등 폴리페놀(polyphenol)계 화합물들이 배당체 형태로 함유되어 있으며, 이들에 의해 항산화 효과, 항당뇨 효과 및 지질대사 개선효과 등 다양한 생리작용이 보고되고 있다.According to the present invention, 'pear (Pyrus pylifolia Nakai)' is an alkaline food rich in saccharides such as glucose and fructose, and vitamins B and C and dietary fiber. It is one of the four fruits of Korea in addition to apples, It has been used for therapeutic purposes such as constipation, diuretic and cough in one room. Recently, pectin, one of the major components of the pear, has been shown to be effective in the treatment of diabetes, lowering cholesterol in blood, improving digestive disorders, and improving cardiovascular disorders. In addition, polyphenol compounds such as catechin, albutin, chlorogenic acid, caffeic acid, epicatechin and rutin, as well as polymeric polysaccharides such as pectin, Diabetic effect, antidiabetic effect, and lipid metabolism improvement effect, and various physiological actions have been reported.
본 발명에 따른, '수수(sorghum, Sorghum bicolor L. Moench)'는 외떡잎식물 벼목 화본과의 한해살이풀로 쌀, 보리, 밀 및 옥수수에 이어 중요한 잡곡의 하나이며, 식이섬유 및 페놀화합물 등의 유효성분이 다량 함유되어 있다. 페놀화합물은 대부분 플라보노이드, 탄닌 및 페놀산 등으로 구성되어 있으며, 이들 페놀화합물은 강한 항돌연변이원성의 활성이 있는 것으로 보고되고 있고, 수수 추출물은 강력한 항산화활성을 나타내는 것으로 알려져 있으며, 콜레스테롤 생합성관련효소인 HMG-CoA 리덕타아제 활성을 억제하는 것으로 밝혀졌다.Sorghum (Sorghum bicolor L. Moench) according to the present invention is an annual herbaceous plant of the alopecia plantus, and is one of the important grains following rice, barley, wheat, and maize, and effective ingredients such as dietary fiber and phenol compounds It is contained in large quantity. Phenol compounds are mostly composed of flavonoids, tannins, and phenolic acids. These phenolic compounds have been reported to have strong antimutagenic activity. The extracts of Ahnsung are known to exhibit strong antioxidant activity, and cholesterol biosynthesis-related enzymes HMG-CoA < / RTI > reductase activity.
본 발명에 따른, '맥문동(Liriope platyphylla Wang et Tang)'은 인체 진액이 부족할때 쓰이는 대표적인 약재이며, 완화 자양강장제로 진해, 거담 및 해열에 사용하며, 감기로 인한 기침, 가래, 기관지염, 폐결핵, 심장 기능 허약 또는 폐의 진액을 보충하기 위한 용도로 사용되기도 한다. 또한, 맥문동은 한의학적으로 신체 허약에 원기를 돋우고 열성병의 구건증 등에 적용하며, 최유제의 보조약으로 통유작용을 가지고 있다. 특히, 맥문동은 노인들의 좋은 보건 건강약으로 애용되어 왔으며 체력의 감퇴를 막는 약재이다. 폐를 보하는 약이므로 아이들이 감기에 잘 걸리는 경우에 많이 쓰이고, 강심작용 또한 있으며, 점액질이 풍부해서 변비에도 응용된다.According to the present invention, 'Liriope platyphylla Wang et Tang' is a typical medicinal drug used when human body fluids are lacking. It is used as an anti-inflammatory tonic for shinhae, gadam and fever, and is used for cough, sputum, bronchitis, It can also be used to supplement cardiac function weakness or the essence of the lungs. In addition, McMundong is an oriental medicine that helps the body to feel weak, and it is applied to the digestive tract of the thermophilic disease, and has the fluidizing action as an adjuvant for the fermentation. Especially, McMundong has been used as a good health health medicine for the elderly and is a medicine to prevent decline of physical strength. Because it is a medicine to protect the lungs, it is often used when children are caught cold. It is also used for the treatment of constipation.
본 발명에 따른, '생강(Zingiber officinale)'은 외떡잎식물 생강목 생강과의 여러해살이풀로서, 이의 뿌리는 식용 및 약용으로 사용된다. 생강의 주성분은 진기베롤(zingiberol), 진기베렌(zingiberene), 펠란드렌(phellandrene), 캄펜(camphene), 시트랄(citral), 리나룰(linalool), 메틸헵테논(methylheptenone), 노닐알데하이드(nonylaldehyde) 및 d-보르네올(d-borneol) 등이다. 혈액순환을 촉진, 해독 및 소염작용을 하며, 치통의 약취를 제거하고 통증을 멎게 하며 습양(濕痒)을 가라앉힌다. 염증을 치료하고 결장을 깨끗이 한다. 경련을 완화하고 혈액순환을 촉진한다.According to the present invention, 'ginger (Zingiber officinale)' is a perennial herb with ginger root ginger and ginger, and its roots are used for edible and medicinal purposes. The main ingredients of ginger are zingiberol, zingiberene, phellandrene, camphene, citral, linalool, methylheptenone, nonylaldehyde nonylaldehyde) and d-borneol (d-borneol). It promotes blood circulation, detoxification and anti-inflammatory action, removes tooth decay, stops pain, and relieves writhing. Treat inflammation and purify the colon. Relieves seizures and promotes blood circulation.
본 발명에 따른, '배초향'은 한방에서는 곽향이라고 하고, 강한 향기를 풍기는 방향성 식물이다. 맵고 따뜻한 약성을 가지며 해열, 발한, 위액분비 촉진, 연동운동 촉진, 신장혈류 개선, 구취제거, 항진균작용 및 소화작용에 효과가 있다.According to the present invention, 'bamboo shoot' is a bamboo shoot in one room and is a bamboo shoot with a strong fragrance. It has a spicy and warm flavor and is effective in fever, sweating, stimulation of gastric juice secretion, stimulation of peristalsis, improvement of blood flow in kidney, removal of bad breath, antifungal action and digestion.
본 발명에 따른, '멘톨'은 한개의 고리로 이루어진 모노테르펜에 속하는 알코올이며, 박하의 잎이나 줄기를 수증기 증류하여 얻는 물질이다. 멘톨은 발한, 해열, 소염, 건위, 담즙분비 촉진, 호흡기 점액분비 촉진, 모세혈관확장, 중추흥분작용 및 자궁수축 증가작용을 한다.
According to the present invention, 'menthol' is an alcohol belonging to monoterpene consisting of a single ring and is a substance obtained by steam distillation of leaves or stems of peppermint. Menthol has effects of sweating, fever, inflammation, dryness, promotion of bile secretion, stimulation of respiratory mucus secretion, capillary vasodilation, central excitatory action and increased uterine contraction.
본 발명의 일 측면에 따르면, 도라지, 더덕, 배, 수수, 맥문동, 생강 및 배초향을 혼합하여 열수 추출재료를 얻는 단계; 상기 혼합물을 열수 추출하여 농축액을 얻는 단계; 상기 농축액에 발효균을 접종하여 발효시키는 단계; 상기 발효된 농축액을 가열 멸균 후 분무 건조하여 건고물을 얻는 단계; 상기 건조된 건고물에 배초향 분말을 혼합하여 혼합물을 얻는 단계; 및 상기 혼합물에 꿀 및 멘톨을 혼합 교반하여 환제로 제조하는 단계;를 포함하는 발효도라지환의 제조방법이 제공될 수 있다.According to an aspect of the present invention, there is provided a method for producing a hot-water-extracting material, comprising the steps of: obtaining a hydrothermal-extracted material by mixing a bellflower, a bellflower, a pear, a millet, Extracting the mixture with hot water to obtain a concentrate; Fermenting the fermentation broth by inoculating the concentrate; Heating and sterilizing the fermented concentrate followed by spray drying to obtain a dried product; Mixing a dried powder with the dried powder to obtain a mixture; And mixing and stirring the mixture with honey and menthol to prepare a pellet.
본 발명의 일 실시예에 따른 발효도라지환의 제조방법의 흐름도를 나타낸 도 1 및 도 2를 참고하여 본 발명에 따른 제조방법을 보다 더 상세히 설명한다.The manufacturing method according to the present invention will be described in more detail with reference to Figs. 1 and 2, which show a flow chart of a method of manufacturing a fermented dorado ring according to an embodiment of the present invention.
본 발명에 따른 발효도라지환의 제조방법은 준비된 약초 중 발휘하고자 하는 약리 효과에 따라 필요한 것을 선별한 후 일부 약초는 열수 추출하고, 나머지 약초는 분쇄하여 분말화한 뒤, 열수 추출되어 건조된 건고물과 분쇄된 분말을 혼합한 환제를 만드는 것을 특징으로 한다.According to the present invention, there is provided a method for producing a fermented Dora soya bean, comprising the steps of selecting necessary herbs according to the pharmacological effect to be exhibited, extracting some herbs by hot water extraction, pulverizing and pulverizing the remaining herbs, And pulverized powders are mixed to form a pellet.
이때, 열수 추출로 얻은 농축액을 건조시킨 열수 추출 건고물 및 농축된 약리성분을 함유하고 있는 분쇄된 분말은 약초가 지닌 치유적 기능을 갖는 고유의 향을 유지하며, 열수 추출 건고물 및 분말을 혼합한 발효도라지환은 농축된 약리 성분 및 치유적 기능을 가진다.The pulverized powder containing the hot-water extractant solids and the concentrated pharmacologically active substance obtained by drying the concentrated liquid obtained by the hot water extraction maintains the inherent flavor possessed by the herb with a therapeutic function and is mixed with the hot- One fermented dorado ring has a concentrated pharmacological component and a healing function.
도 1에 나타난 바와 같이, 본 발명에 따른 발효도라지환의 제조방법은 약초를 준비하는 단계(st100); 상기 약초 중 필요한 것을 선택하여 열수 추출하고, 건조시켜 열수 추출 건고물을 얻는 단계(st200); 상기 약초 중 필요한 것을 선택한 뒤 분쇄하여 분말을 얻는 단계(st300); 상기 열수 추출 건고물과 상기 분말을 혼합하여 혼합물을 얻는 단계(st400); 상기 혼합물에 꿀 및 멘톨을 첨가하고 혼합 교반하는 단계(st500); 및 소형의 환을 제조하는 단계(st600);를 포함한다.As shown in FIG. 1, a method for producing a fermented dalyeose pendulum according to the present invention comprises: preparing an herb (st100); Selecting a necessary one of the herbs, extracting it by hot water, and drying it to obtain a hot-water-extracting product (st200); Selecting a desired one of the herbs and pulverizing them to obtain a powder (st300); (St400) mixing the hydrothermal extractant solids and the powder to obtain a mixture; Adding honey and menthol to the mixture and mixing and stirring (st 500); And manufacturing a small-sized ring (st600).
각각의 단계를 구체적으로 살펴보면 다음과 같다.Each step will be described in detail as follows.
약초를 준비하는 단계(st100)는 도라지, 더덕, 배, 수수, 맥문동, 생강 및 배초향 등(반드시 이에 제한되지 않음)을 좋은 품질의 것으로 선별하고, 세척한 다음 잘 말려 준비해 놓는 원재료 준비단계이다. 이때, 각 약초들의 성질과 특징에 따라 시기별로 좋은 약초를 채취 보관하고 필요시 적정량을 사용하는 것이 바람직하다. 각각의 약초 혼합 비율 및 처리과정은 후술하는 해당 부분의 설명으로 쉽게 이해할 수 있다.The step of preparing the herb (st100) is a raw material preparing step in which the bellflower, bellflower, ginseng, ginseng, ginger, and pearl bees are selected with good quality, washed, cleaned and prepared. At this time, it is preferable to collect and store good herbs according to the characteristics and characteristics of each herb and use an appropriate amount when necessary. Each herbicide blending ratio and treatment process can be easily understood by the description of the corresponding part to be described later.
다음으로, 열수 추출 건고물을 얻는는 단계(st200)는 준비된 약초 중 필요한 효능이 발휘되게 선택된 약초를 열수 추출하고 건조시키는 과정이다.Next, the step (st200) of obtaining a hot-water extracting tincture is a step of hot-water extraction and drying of the herb selected for the desired effect from the prepared herb.
이에 대하여, 도 2를 참고하여 보다 구체적인 과정을 살펴본다. In the meantime, a more detailed process will be described with reference to FIG.
도 2에 나타난 바와 같이, 준비된 약초 중 효능에 맞게 혼합될 약초를 선택하여 열수 추출 재료를 준비한다(st210). As shown in Fig. 2, the herb selected to be mixed with the herbal medicine prepared in accordance with the efficacy is selected to prepare a hot-water extraction material (st210).
일 실시예에 있어서, 선택된 약초는 혼합물 기준으로 도라지 25 ± 0.05중량%, 더덕 5 ± 0.05중량%, 배 5 ± 0.05중량%, 수수 5 ± 0.05중량%, 맥문동 4 ± 0.05중량%, 및 생강 3 ± 0.05중량%로 준비된다. 이는 상기 약초의 혼합 비율 중 도라지, 더덕, 및 맥문동의 배합비율은 거담실험에서 얻은 조건이며, 여기에 배와 수수를 넣은 것은 전통적인 도라지조청 제조방식을 접목시키 것으로서, 상기의 비율로 혼합될 경우 거담 기능개선 및 두뇌활동 촉진에 관한 약리 효과가 유효하게 발휘되는 것으로 확인하였다.In one embodiment, the selected herb is selected from the group consisting of 25 ± 0.05 wt.% Platelets, 5 ± 0.05 wt.% Dodec, 5 ± 0.05 wt.%, 5 ± 0.05 wt. 0.05% by weight. This is because the blending ratio of the herbaceous herbs is the condition obtained from the germane experiment, and the blending ratio of the herbaceous herb is higher than that of the traditional herb preparation. It was confirmed that the pharmacological effect on improvement of function and promotion of brain activity is effectively exercised.
다음으로, 이와 같이 준비된 열수 추출재료는 균질하게 혼합된 상태로 열수에 증자시켜 0.0067%의 농축액을 열수 추출한다(st220). Next, the hot water extraction material thus prepared is added to hot water in a homogeneously mixed state, and a concentrate of 0.0067% is subjected to hot water extraction (st220).
일 실시예에 있어서, 상기 열수 추출은 121 ± 10℃의 온도 조건에서 30~40분동안 증자할 수 있으며, 반드시 이에 제한되지 않는다. 상기의 온도 조건 및 증자 시간은 예비실험에서 얻은 조건이다. 즉, 1기압 이상에서 상기의 온도 조건 범위 내에서 30~40분동안 증자한 경우 시간 대비 최적의 열수 추출 효율을 얻을 수 있었다.In one embodiment, the hot water extraction is performed at a temperature of < RTI ID = 0.0 > 121 C < / RTI & And may be, but is not necessarily limited to. The above-mentioned temperature conditions and the time for the increase were the conditions obtained in the preliminary experiment. That is, when the temperature was increased from 1 atm to 30 to 40 minutes within the above temperature range, optimum hot water extraction efficiency was obtained.
다음으로, 상기 농축액에 발효균을 접종시켜 발효시킨다(st230). Next, fermenting bacteria are inoculated into the concentrate and fermented (st230).
일 실시예에 있어서, 상기 발효균은 한약재 발효산물의 교미교취를 통한 복약 순응도를 증대시키고 효과적을 발효를 위해서 사카로마이시스 세레비시에(Saccharomyces cerevisiae C-2)를 주모로 사용하는 것이 바람직하고, 또한, 발효과정에서 항온 및 항습을 유지시키기 위해 온도 27 ± 10℃, 습도 60%를 유지하는 것이 바람직하다. 상기의 발효과정은 12 ~ 24시간을 거쳐 완성된다.In one embodiment, it is preferable that the fermenting microorganism uses Saccharomyces cerevisiae C-2 as its master in order to increase compliance with medicines through mating of fermented products of herbal medicines and effective fermentation, , It is desirable to maintain a temperature of 27 ± 10 ° C and a humidity of 60% in order to maintain constant temperature and humidity during the fermentation process. The above fermentation process is completed through 12 to 24 hours.
다음으로, 발효된 상기 농축액을 가열하여 멸균시킨다(st240). Next, the fermented concentrate is heated and sterilized (st240).
일 실시예에 있어서, 상기 가열 멸균은 121 ± 10℃의 온도 조건에서, 30 ~ 40분동안 수행될 수 있으며, 상기의 온도 조건 및 멸균 시간은 예비실험에서 얻은 조건이다. 즉, 1기압 이상에서 상기의 온도 조건 범위 내에서 30~40분동안 증자한 경우 시간 대비 최적의 열수 추출 효율을 얻을 수 있었다.In one embodiment, the heat sterilization may be performed at a temperature of 121 ± 10 ° C for 30 to 40 minutes, and the temperature condition and the sterilization time are conditions obtained in a preliminary experiment. That is, when the temperature was increased from 1 atm to 30 to 40 minutes within the above temperature range, optimum hot water extraction efficiency was obtained.
다음으로, 멸균된 상기 농축액을 분무하여 건조시킨다(st250). Next, the sterilized concentrated liquid is sprayed and dried (st250).
일 실시예에 있어서, 상기 건조는 121℃ 이하에서 진행되는 것이 바람직하고, 이와 같은 온도 조건은 분무 건조기의 수율과 건조된 건고물의 약효 손실을 최소화하는 조건으로 예비실험에서 얻은 조건이다. In one embodiment, the drying is preferably carried out at a temperature of 121 ° C or lower, and such a temperature condition is a condition obtained in a preliminary experiment to minimize the yield of the spray dryer and the efficacy of the dried dry solids.
다음으로, 농축액이 건조된 건고물에 유당을 배합하는 것으로 열수 추출 건고물의 준비를 완료한다(st260). Next, the preparation of the hot-water extracting granules is completed by adding lactose to the dry solid of the concentrated liquid (st260).
일 실시예에 있어서, 상기 유당은 설탕, 흑설탕 등을 사용할 수 있으며, 바람직하게는 탈지한 유당을 사용하고 상기 건조된 건고물과 1:1의 비율로 배합될 수 있다. 이는 건고물의 원활한 교반을 위함이며, 예비실험에서 얻은 조건이다.
In one embodiment, the lactose may be sugar, brown sugar or the like, preferably using a degreased lactose, and may be blended at a ratio of 1: 1 with the dried dry solid. This is for the smooth agitation of dry matter and is the condition obtained from preliminary experiments.
상기의 열수 추출 건고물의 준비와는 별도로 하기와 같이 분말이 준비된다.Apart from the preparation of the hot water-extracting agent solids described above, powders are prepared as follows.
약초 중 필요한 것을 선택한 뒤 분쇄하여 분말을 얻는 단계(st300)는 준비된 약초 중 필요한 효능이 발휘되게 선택된 약초를 분쇄하고 혼합시키는 과정으로, 효능에 맞게 혼합될 약초를 선택하여 분말재료를 준비한다. 상기와 같이 준비된 상기 열수 추출 건고물 및 상기 분말을 혼합하여 혼합물을 얻는다(st400). 다음으로, 상기 혼합물에 꿀 및 멘톨을 첨가하고 혼합 교반한다(st500). The step (st300) of obtaining the powder by selecting one of herbal medicines and pulverizing is a process of pulverizing and mixing medicinal herbs selected for the necessary effects among prepared herbs, and preparing the powdery material by selecting the herb to be mixed with the effect. The prepared hot-water-extracting tin and the powder are mixed to obtain a mixture (st400). Next, honey and menthol are added to the mixture and mixed and stirred (st 500).
일 실시예에 있어서, 혼합비율은, 바람직하게는 전체 조성물 대비 상기 열수 추출 건고물 및 분말의 혼합물 49.8 ± 0.5중량%, 꿀 50 ± 0.5중량%, 멘톨 0.2 ± 0.5중량%일 수 있으나, 반드시 이에 제한되는 것은 아니다.In one embodiment, the mixing ratio may be preferably 49.8. + -. 0.5% by weight of the hot water-extracting agent mixture and powder, 50 + 0.5% by weight of honey and 0.2 + 0.5% by weight of menthol, But is not limited to.
다음으로, 상기 st500단계에서 생성된 혼합물로부터 소형의 환을 제조한다(st600). 이때, 상기 환제는 그 중량이 4 g 인 것이 바람직하나, 반드시 이에 제한되는 것은 아니다. Next, a small circle is prepared from the mixture produced in the step st500 (st600). At this time, the weight of the pellet is preferably 4 g, but is not limited thereto.
일 실시예에 있어서, 상기 제조된 환제를 121 ± 10℃의 온도 조건에서, 수분 함량이 20% 미만이 되도록 건조되는 단계를 더 포함할 수 있다.In one embodiment, the produced pellets may further be dried at a temperature of 121 ± 10 ° C so that the water content is less than 20%.
또한, 본 발명의 다른 측면에 따르면, 상기의 방법으로 제조된 발효도라지환이 제공될 수 있다.
According to another aspect of the present invention, there is provided a fermented dalyeoseol produced by the above method.
이하에서는 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 다만, 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다 할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. It should be understood, however, that these examples are for illustrative purposes only and are not to be construed as limiting the scope of the present invention.
발효 Fermentation 도라지환의Bellflower 제조 Produce
도라지, 더덕, 배, 수수, 맥문동, 생강 및 배초향을 혼합물 기준 도라지 25중량%, 더덕 5중량%, 배 5중량%, 수수 5중량%, 맥문동 4중량% 및 생강 3중량%으로 혼합하여 열수 추출재료로 준비하였다.5% by weight, 5% by weight, 5% by weight, 4% by weight of gumgangdong and 3% by weight of ginger were mixed with each other and subjected to hot water extraction Materials were prepared.
상기의 발효도라지환에 사용된 약초의 배합 의의는 하기의 표 1과 같다.The compounding significance of the herb used in the above-mentioned fermented Doria's ring is shown in Table 1 below.
상기 열수 추출재료를 121℃에서 30분간 열수 추출하여 0.0067%의 농축액을 얻었다. 상기 농축액으로 사카로마이시스 세레비시에(Saccharomyces cerevisiae C-2) 주모를 접종하고, 상온 27℃ 및 습도 60% 조건에서 18시간동안 발효시켰다. 발효된 상기 농축액을 121℃에서 30분간 멸균되었으며, 멸균된 상기 농축액을 분무하여 121℃ 이하에서 건고물로 건조시켰다.The hot water extraction material was subjected to hot water extraction at 121 DEG C for 30 minutes to obtain a concentrate of 0.0067%. The concentrate was inoculated with Saccharomyces cerevisiae C-2 maize and fermented for 18 hours at a temperature of 27 ° C and a humidity of 60%. The fermented concentrate was sterilized at 121 DEG C for 30 minutes, and the sterilized concentrate was sprayed and dried to dryness at 121 DEG C or less.
상기 건고물에 탈지한 유당을 1:1의 비율로 배합하여 열수 추출 건고물을 준비하였으며, 여기에 분쇄된 배초향 분말을 혼합물 기준 2.8중량%로 혼합하였다. 다음으로, 상기 혼합물에 꿀 50.0% 및 멘톨 0.2%를 혼합 교반시켜 환제를 제조한 후, 상기 환제를 121℃ 이하에서 건조시켜 수분함량을 20% 미만으로 낮췄다.
The dry solid was blended with the degreased lactose at a ratio of 1: 1 to prepare a hot water-extracted dry cake. The pulverized liquid powder was mixed with 2.8% by weight based on the mixture. Next, 50.0% of honey and 0.2% of menthol were mixed and stirred to prepare a pellet, and the pellet was dried at 121 ° C or lower to reduce the water content to less than 20%.
즉, 상기에 기재된 바와 같이, 본 발명에 따르면, 발효된 도라지 추출물에 한방약초를 혼합 농축시켜 거담 기능개선 및 두뇌활동 촉진에 관한 약리 효과가 있는 발효도라지환 및 이의 제조방법이 제공되며, 이에 따라 약리 효과가 있는 발효된 도라지 추출물 및 다양한 한방약초를 휴대가 용이하며, 산제와는 달리 복용량이 일정한 장점이 있는 환제로 조제할 수 있다.
That is, as described above, according to the present invention, there is provided a fermented Dorafill ring having a pharmacological effect on improvement of a dahingham function and brain activity promotion by mixing and concentrating herb medicine with fermented Platycodon grandiflorum extract and a method for producing the same Fermented phytophthora berry extract with various pharmacological effects and various oriental medicine herbs are easy to carry and can be prepared with a pill which has the advantage of having a constant dose, unlike the acid.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는바, 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시 양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항 들과 그것들의 등가물에 의하여 정의된다고 할 것이다.
While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, It will be obvious that it is not. It is therefore intended that the scope of the invention be defined by the claims appended hereto and their equivalents.
Claims (5)
상기 얻어진 열수 추출재료를 열수 추출하여 농축액을 얻는 단계;
상기 얻어진 농축액에 발효균을 접종하여 발효시키는 단계;
상기 발효된 농축액을 가열 멸균 후 분무 건조하여 건고물을 얻는 단계;
상기 건조된 건고물에 배초향 분말을 혼합하여 혼합물을 얻는 단계;
상기 얻어진 혼합물에 꿀 및 멘톨을 혼합 교반하여 환제로 제조하는 단계; 및
상기 제조된 환제를 121 ± 10℃의 온도 조건에서, 수분 함량이 20% 미만이 되도록 건조하는 단계;를 포함하는 발효도라지환의 제조방법.
Obtaining a hydrothermal extracting material by mixing bellflower, dodecahedron, belly, sorghum, marshmallow, and ginger;
Extracting the obtained hot water extraction material with hot water to obtain a concentrated liquid;
Fermenting the obtained concentrated liquid by inoculating the fermenting bacteria;
Heating and sterilizing the fermented concentrate followed by spray drying to obtain a dried product;
Mixing a dried powder with the dried powder to obtain a mixture;
Mixing the obtained mixture with honey and menthol to prepare a pellet; And
Drying the prepared pellet to a moisture content of less than 20% at a temperature of 121 ± 10 ° C.
상기 열수 추출재료는 전체 혼합물 대비 도라지 25 ± 0.05중량%, 더덕 5 ± 0.05중량%, 배 5 ± 0.05중량%, 수수 5 ± 0.05중량%, 맥문동 4 ± 0.05중량% 및 생강 3 ± 0.05중량%; 상기 배초향 분말은 전체 혼합물 대비 2.8 ± 0.5중량%; 및 상기 꿀 및 멘톨은 전체 혼합물 대비 꿀 50 ± 0.5중량% 및 멘톨 0.2 ± 0.5중량%;로 혼합되는 것인 발효도라지환의 제조방법.The method according to claim 1,
Wherein the hot water extracting material comprises 25 ± 0.05% by weight of the total mixture, 5 ± 0.05% by weight of dodec, 5 ± 0.05% by weight of pear, 5 ± 0.05% by weight of corn, 4 ± 0.05% by weight of corn germ and 3 ± 0.05% by weight of ginger; 2.8 ± 0.5% by weight of the whole mixture; And the honey and menthol are mixed in an amount of 50 ± 0.5% by weight of honey and 0.2 ± 0.5% by weight of menthol, based on the whole mixture.
상기 열수 추출 및 가열 멸균은 121 ± 10℃의 온도 조건에서, 30 ~ 40분동안 수행하는 발효도라지환의 제조방법.
The method according to claim 1,
Wherein the hot water extraction and heat sterilization are carried out at a temperature of 121 ± 10 ° C for 30 to 40 minutes.
상기 건조된 건고물에 탈지한 유당을 1:1의 비율로 배합하는 단계를 더 포함하는 발효도라지환의 제조방법.
The method according to claim 1,
Further comprising the step of blending the dried beans with the defatted lactose at a ratio of 1: 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120128608A KR101402852B1 (en) | 2012-11-14 | 2012-11-14 | Fermented bellflower pills and Preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120128608A KR101402852B1 (en) | 2012-11-14 | 2012-11-14 | Fermented bellflower pills and Preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140062230A true KR20140062230A (en) | 2014-05-23 |
KR101402852B1 KR101402852B1 (en) | 2014-06-02 |
Family
ID=50890548
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120128608A KR101402852B1 (en) | 2012-11-14 | 2012-11-14 | Fermented bellflower pills and Preparation thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101402852B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160056482A (en) * | 2014-11-11 | 2016-05-20 | 경남과학기술대학교 산학협력단 | Fermented bellflower root candy and method for preparation thereof |
KR20210067708A (en) * | 2019-11-29 | 2021-06-08 | 박연숙 | Manufacturing method of black balloon flower pill |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200119005A (en) | 2019-04-09 | 2020-10-19 | 이재원 | Method for manufacturing black ballon flower roots and the black ballon flower roots thereby |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100607791B1 (en) | 2002-12-23 | 2006-08-02 | 권순직 | Manu facturing process of assistant food for the protection of bronchus and the respiratory organs |
KR100895110B1 (en) | 2007-04-27 | 2009-04-28 | 주식회사 유엔아이 | Black garlic fermented by natural herb, processes for the preparation thereof, and health food comprising the same |
KR100881367B1 (en) | 2007-07-13 | 2009-02-02 | 세명한방제약 주식회사 | Method for manufacturing a pill of eating raw including Houttuynia cordata Thunb and saururus chinensis Baill and the pill made by the same |
KR100840896B1 (en) | 2007-10-24 | 2008-06-24 | 양재열 | Preparation method of red/black platycodon and health food using the same |
-
2012
- 2012-11-14 KR KR1020120128608A patent/KR101402852B1/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160056482A (en) * | 2014-11-11 | 2016-05-20 | 경남과학기술대학교 산학협력단 | Fermented bellflower root candy and method for preparation thereof |
KR20210067708A (en) * | 2019-11-29 | 2021-06-08 | 박연숙 | Manufacturing method of black balloon flower pill |
Also Published As
Publication number | Publication date |
---|---|
KR101402852B1 (en) | 2014-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103749982B (en) | Feed for improving egg yield, traditional Chinese medicine additive and preparation method thereof | |
CN103099089A (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
KR20200004942A (en) | Composition for Liver Protection Containing Hub Extract and Beverage Thereof | |
KR20130104692A (en) | Composition foranti-obesity using extract of crataegi fructus | |
KR20070000573A (en) | The heath food having an effect on dropping blood sugar and constipation | |
KR20170072003A (en) | Method of manufacturing a fermented food that can help diabetes using the Hordeum vulgare L. and fermented food that has been produced by it | |
CN103372047A (en) | Eucommia bark buccal tablets and preparation method thereof | |
CN108813501B (en) | Health-preserving honey paste with functions of clearing heat, moistening lung, relieving cough, reducing phlegm, relieving asthma and regulating human body functions | |
KR101402852B1 (en) | Fermented bellflower pills and Preparation thereof | |
KR101830048B1 (en) | Food composition for improvement obesity or improvement hyperlipidemic with the extract of Terminalia chebula fruit and Phyllanthus emblica | |
CN108157547A (en) | A kind of King solomonseal rhizome tea and its preparation process for improving yin-deficiency constitution | |
CN112515014A (en) | Kudzuvine root polysaccharide sweet zong black tea and preparation method thereof | |
KR102168192B1 (en) | Healthful mixed tea development using fermented herbs, fruits and shiitake | |
CN106722728A (en) | The formula and preparation method of a kind of auxotype composite aromatic condiment | |
CN108651652A (en) | Witloof compound surrogated tea | |
KR20210063657A (en) | A natural tea removing the effect of hangover contained the extract material in Hovenia dulcis and a cactus | |
CN102835534A (en) | Preparation method of compound ginseng and black ginkgo nut filled chocolate | |
KR20100102890A (en) | Process of manufacture of ability drink that use medicinal plant extraction liquid | |
CN108260682A (en) | A kind of hypoglycemic, reducing blood lipid and the health protection tea of blood pressure lowering | |
CN108578589B (en) | Composite effervescent tablet for relieving alcoholism and preparation method thereof | |
CN105639517A (en) | Loquat lotion and preparation method thereof | |
KR100815333B1 (en) | Healthfood using medicalherbs and method preparing thereof | |
KR20210041387A (en) | A natural tea removing the effect of hangover contained the extract material in arrowroot blossoms and Plantago ovata | |
Algethami et al. | Bee pollen: Clinical trials and patent applications. Nutrients. 2022, 14, 2858 | |
CN103478334A (en) | Preparation method for hawthorn bodybuilding and fat elimination tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170526 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180525 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |